The additional equipment train will allow for increased scalability into full-scale manufacturing in support of growing client demand.

CoreRx is a contract research organization providing formulation development, preformulation, analytical, and clinical trial manufacturing to American and European companies since 2006. The company is renowned for reliably expediting early development activities to   speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. CoreRx’s unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into CoreRx.

As a fully cGMP contract facility, CoreRx provides formulation development, analytical, and clinical material resources, utilizing a variety of multi-layer tablet equipment for combination products. CoreRx also offers development and manufacture of multi-particulate combination drug products. Whether your need is for multiple tablets in a capsule, pellets, granules, nano-particles, co-processed spray dried powders or multiple powders in capsules, CoreRx has you covered.

About CoreRx: Keep on top of new developments and throughout the drug development industry by following us on Twitter: www.twitter.com/CoreRx. For more detailed information about us, visit www.corerxpharma.com.